We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Low Leverage Stocks to Buy on Expectations of Rate Cuts
Read MoreHide Full Article
Major U.S. stock indices witnessed an uptick on Jan 22, with the S&P 500 and the Dow Jones industrial average each making an upward move. This was most likely driven by investors’ optimism surrounding Fed rate cuts expected this year, backed by easing inflation.
Against this backdrop, stock market players might be in the mood for some good investments. However, since the share market has lately been on edge, we recommend stocks like Insight Enterprise (NSIT - Free Report) , Arcosa (ACA - Free Report) , Cardinal Health (CAH - Free Report) , Photronics (PLAB - Free Report) and Wingstop (WING - Free Report) , which bear low leverage. Choosing them can shield investors from incurring huge losses in times of crisis.
Now, before selecting low-leverage stocks, let’s explore what leverage is and how choosing a low-leverage stock helps investors.
In finance, leverage is a term used to denote the practice of borrowing capital by companies to run their operations smoothly and expand the same. Such borrowings are done through debt financing. But there remains an option for equity finance. This is probably due to the cheap and easy availability of debt over equity financing.
However, debt financing has its share of drawbacks. Particularly, it is desirable only as long as it successfully generates a higher rate of return compared to the interest rate. So, to avoid considerable losses in your portfolio, one should always avoid companies that resort to exorbitant debt financing.
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find.
The equity market can be volatile at times, and, as an investor, if you don’t want to lose big time, we suggest you invest in stocks that bear low leverage and are, hence, less risky.
To identify such stocks, historically, several leverage ratios have been developed to measure the amount of debt a company bears and the debt-to-equity ratio is one of the most common ratios.
Analyzing Debt/Equity
Debt-to-Equity Ratio = Total Liabilities/Shareholders’ Equity
This metric is a liquidity ratio that indicates the amount of financial risk a company bears. A lower debt-to-equity ratio reflects improved solvency for a company.
As the fourth-quarter earnings cycle has already started, investors must be eyeing stocks that have exhibited solid earnings growth in the recent past. But if a stock bears a high debt-to-equity ratio in times of economic downturn, its so-called booming earnings picture might turn into a nightmare.
The Winning Strategy
Considering the aforementioned factors, it is prudent to choose stocks with a low debt-to-equity ratio to ensure steady returns.
Yet, an investment strategy based solely on the debt-to-equity ratio might not fetch the desired outcome. To choose stocks that have the potential to give you steady returns, we have expanded our screening criteria to include some other factors.
Here are the other parameters:
Debt/Equity less than X-Industry Median: Stocks that are less leveraged than their industry peers.
Current Price greater than or equal to 10: The stocks must be trading at a minimum of $10 or above.
Average 20-day Volume greater than or equal to 50000: A substantial trading volume ensures that the stock is easily tradable.
Percentage Change in EPS F(0)/F(-1) greater than X-Industry Median: Earnings growth adds to optimism, leading to a stock’s price appreciation.
VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy), offer the best upside potential.
Estimated One-Year EPS Growth F(1)/F(0) greater than 5: This shows earnings growth expectation.
Zacks Rank #1 or 2: Irrespective of market conditions, stocks with a Zacks Rank #1 or 2 have a proven history of success.
Excluding stocks that have a negative or a zero debt-to-equity ratio, here we present our five picks out of the 27 stocks that made it through the screen.
Insight Enterprises: It is a global direct marketer of branded computers, hardware and software. On Dec 1, 2023, Insight Enterprises stated that it had completed the acquisition of SADA, a leading cloud business and technology consultancy and a six-time Google Cloud Partner of the Year. The acquisition should strengthen NSIT’s unique position as a leading Solutions Integrator offering market-leading multi-cloud solutions at scale.
NSIT delivered an earnings surprise of 4.12% in the last reported quarter. It sports a Zacks Rank #1 currently. The Zacks Consensus Estimate for fourth-quarter 2023 earnings suggests a 20.2% improvement from the fourth-quarter 2022 reported figure.
Arcosa: The company is a manufacturer of infrastructure-related products and services, which serve construction, energy and transportation markets. On Nov 1, 2023, Arcosa announced its third-quarter 2023 results. Its adjusted net income improved a solid 7% on a year-over-year basis, while free cash flow dropped 96%.
ACA currently carries a Zacks Rank #2. The company delivered an earnings surprise of 4.12% in the last reported quarter. The Zacks Consensus Estimate for fourth-quarter 2023 earnings suggests an 8.9% improvement year over year.
Cardinal Health: It is a drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. On Jan 9, 2024, Cardinal Health announced progress on its ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure.
To support increased demand for its at-Home Solutions business, the company is investing in network expansion. It plans to build a new distribution center in Texas, with increased capacity, advanced automation and robotics within the facility. The company also updated its fiscal year 2024 non-GAAP EPS guidance to the high end of the $6.75 to $7.00 range.
CAH currently carries a Zacks Rank #2. The company boasts a long-term earnings growth rate of 15.3%. The Zacks Consensus Estimate for CAH’s fiscal 2024 sales indicates an improvement of 10.4% from the fiscal 2023 reported figure. You can see the complete list of today’s Zacks #1 Rank stocks here.
Photronics: It is a leading worldwide manufacturer of photomasks, which are high-precision quartz plates that contain microscopic images of electronic circuits. On Dec 13, 2023, Photronics reported financial results for its full year and fourth quarter of fiscal year 2023. Its fourth-quarter revenues improved a solid 8% year over year, while adjusted net income surged 22.9%.
PLAB currently sports a Zacks Rank #1. The company delivered an average four-quarter earnings surprise of 8.51%. The Zacks Consensus Estimate for PLAB’s fiscal 2024 earnings suggests a 27.5% improvement from the fiscal 2023 reported figure.
Wingstop: It franchises and operates restaurants. On Nov 1, 2023, the company announced financial results for fiscal third-quarter 2023. Its system-wide sales increased 26.5% to $885 million.
WING currently carries a Zacks Rank #2. The company boasts a long-term earnings growth rate of 21.8%. The Zacks Consensus Estimate for WING’s fiscal 2024 sales suggests a 26.4% improvement from the 2022 reported figure.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and backtest them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
5 Low Leverage Stocks to Buy on Expectations of Rate Cuts
Major U.S. stock indices witnessed an uptick on Jan 22, with the S&P 500 and the Dow Jones industrial average each making an upward move. This was most likely driven by investors’ optimism surrounding Fed rate cuts expected this year, backed by easing inflation.
Against this backdrop, stock market players might be in the mood for some good investments. However, since the share market has lately been on edge, we recommend stocks like Insight Enterprise (NSIT - Free Report) , Arcosa (ACA - Free Report) , Cardinal Health (CAH - Free Report) , Photronics (PLAB - Free Report) and Wingstop (WING - Free Report) , which bear low leverage. Choosing them can shield investors from incurring huge losses in times of crisis.
Now, before selecting low-leverage stocks, let’s explore what leverage is and how choosing a low-leverage stock helps investors.
In finance, leverage is a term used to denote the practice of borrowing capital by companies to run their operations smoothly and expand the same. Such borrowings are done through debt financing. But there remains an option for equity finance. This is probably due to the cheap and easy availability of debt over equity financing.
However, debt financing has its share of drawbacks. Particularly, it is desirable only as long as it successfully generates a higher rate of return compared to the interest rate. So, to avoid considerable losses in your portfolio, one should always avoid companies that resort to exorbitant debt financing.
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find.
The equity market can be volatile at times, and, as an investor, if you don’t want to lose big time, we suggest you invest in stocks that bear low leverage and are, hence, less risky.
To identify such stocks, historically, several leverage ratios have been developed to measure the amount of debt a company bears and the debt-to-equity ratio is one of the most common ratios.
Analyzing Debt/Equity
Debt-to-Equity Ratio = Total Liabilities/Shareholders’ Equity
This metric is a liquidity ratio that indicates the amount of financial risk a company bears. A lower debt-to-equity ratio reflects improved solvency for a company.
As the fourth-quarter earnings cycle has already started, investors must be eyeing stocks that have exhibited solid earnings growth in the recent past. But if a stock bears a high debt-to-equity ratio in times of economic downturn, its so-called booming earnings picture might turn into a nightmare.
The Winning Strategy
Considering the aforementioned factors, it is prudent to choose stocks with a low debt-to-equity ratio to ensure steady returns.
Yet, an investment strategy based solely on the debt-to-equity ratio might not fetch the desired outcome. To choose stocks that have the potential to give you steady returns, we have expanded our screening criteria to include some other factors.
Here are the other parameters:
Debt/Equity less than X-Industry Median: Stocks that are less leveraged than their industry peers.
Current Price greater than or equal to 10: The stocks must be trading at a minimum of $10 or above.
Average 20-day Volume greater than or equal to 50000: A substantial trading volume ensures that the stock is easily tradable.
Percentage Change in EPS F(0)/F(-1) greater than X-Industry Median: Earnings growth adds to optimism, leading to a stock’s price appreciation.
VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy), offer the best upside potential.
Estimated One-Year EPS Growth F(1)/F(0) greater than 5: This shows earnings growth expectation.
Zacks Rank #1 or 2: Irrespective of market conditions, stocks with a Zacks Rank #1 or 2 have a proven history of success.
Excluding stocks that have a negative or a zero debt-to-equity ratio, here we present our five picks out of the 27 stocks that made it through the screen.
Insight Enterprises: It is a global direct marketer of branded computers, hardware and software. On Dec 1, 2023, Insight Enterprises stated that it had completed the acquisition of SADA, a leading cloud business and technology consultancy and a six-time Google Cloud Partner of the Year. The acquisition should strengthen NSIT’s unique position as a leading Solutions Integrator offering market-leading multi-cloud solutions at scale.
NSIT delivered an earnings surprise of 4.12% in the last reported quarter. It sports a Zacks Rank #1 currently. The Zacks Consensus Estimate for fourth-quarter 2023 earnings suggests a 20.2% improvement from the fourth-quarter 2022 reported figure.
Arcosa: The company is a manufacturer of infrastructure-related products and services, which serve construction, energy and transportation markets. On Nov 1, 2023, Arcosa announced its third-quarter 2023 results. Its adjusted net income improved a solid 7% on a year-over-year basis, while free cash flow dropped 96%.
ACA currently carries a Zacks Rank #2. The company delivered an earnings surprise of 4.12% in the last reported quarter. The Zacks Consensus Estimate for fourth-quarter 2023 earnings suggests an 8.9% improvement year over year.
Cardinal Health: It is a drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. On Jan 9, 2024, Cardinal Health announced progress on its ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure.
To support increased demand for its at-Home Solutions business, the company is investing in network expansion. It plans to build a new distribution center in Texas, with increased capacity, advanced automation and robotics within the facility. The company also updated its fiscal year 2024 non-GAAP EPS guidance to the high end of the $6.75 to $7.00 range.
CAH currently carries a Zacks Rank #2. The company boasts a long-term earnings growth rate of 15.3%. The Zacks Consensus Estimate for CAH’s fiscal 2024 sales indicates an improvement of 10.4% from the fiscal 2023 reported figure. You can see the complete list of today’s Zacks #1 Rank stocks here.
Photronics: It is a leading worldwide manufacturer of photomasks, which are high-precision quartz plates that contain microscopic images of electronic circuits. On Dec 13, 2023, Photronics reported financial results for its full year and fourth quarter of fiscal year 2023. Its fourth-quarter revenues improved a solid 8% year over year, while adjusted net income surged 22.9%.
PLAB currently sports a Zacks Rank #1. The company delivered an average four-quarter earnings surprise of 8.51%. The Zacks Consensus Estimate for PLAB’s fiscal 2024 earnings suggests a 27.5% improvement from the fiscal 2023 reported figure.
Wingstop: It franchises and operates restaurants. On Nov 1, 2023, the company announced financial results for fiscal third-quarter 2023. Its system-wide sales increased 26.5% to $885 million.
WING currently carries a Zacks Rank #2. The company boasts a long-term earnings growth rate of 21.8%. The Zacks Consensus Estimate for WING’s fiscal 2024 sales suggests a 26.4% improvement from the 2022 reported figure.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and backtest them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.